1. Home
  2. Labeler Index
  3. Haemonetics Corporation
  4. 53157-123
  5. NDC Package Code: 53157-123-01 Leukotrap - Cp2d Solution

NDC Package 53157-123-01 Leukotrap - Cp2d Solution

Anticoagulant Citrate Phosphate Double Dextrose Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
53157-123-01
Package Description:
6 BAG in 1 POUCH / 70 mL in 1 BAG (53157-123-00)
Product Code:
53157-123
Proprietary Name:
Leukotrap - Cp2d Solution
Non-Proprietary Name:
Anticoagulant Citrate Phosphate Double Dextrose
Substance Name:
Dextrose
Usage Information:
This product is used to treat low blood sugar levels. Symptoms of low blood sugar include sudden sweating, cold skin, shaking, irritability, fast heartbeat, hunger, blurred vision, dizziness, or tingling hands/feet. It is a good habit to carry glucose tablets, liquid, or gel to treat low blood sugar. If you don't have these reliable forms of glucose, rapidly raise your blood sugar by eating a quick source of sugar such as table sugar, honey, or candy, or drink fruit juice or non-diet soda. To help prevent low blood sugar, eat meals on a regular schedule, and do not skip meals. Check with your doctor or pharmacist about what to do if you miss a meal.
11-Digit NDC Billing Format:
53157012301
Product Type:
Human Prescription Drug
Labeler Name:
Haemonetics Corporation
Dosage Form:
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • DEXTROSE 3.57 g/70mL
    • Sample Package:
    No
    FDA Application Number:
    BN820915
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    11-09-1983
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 53157-123-01?

    The NDC Packaged Code 53157-123-01 is assigned to a package of 6 bag in 1 pouch / 70 ml in 1 bag (53157-123-00) of Leukotrap - Cp2d Solution, a human prescription drug labeled by Haemonetics Corporation. The product's dosage form is solution and is administered via intravenous form.

    Is NDC 53157-123 included in the NDC Directory?

    Yes, Leukotrap - Cp2d Solution with product code 53157-123 is active and included in the NDC Directory. The product was first marketed by Haemonetics Corporation on November 09, 1983 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 53157-123-01?

    The 11-digit format is 53157012301. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-253157-123-015-4-253157-0123-01